Brevilin A

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

可选规格

包装

价格

促销价

数量
5mg

￥3800.00

3500.00

- +
10mg

￥5000.00

4000.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Brevilin A 是一种从 Centipeda minima 中分离的倍半萜内酯，具有抗癌活性。Brevilin A 是一种选择性的 JAK-STAT 信号通路抑制剂，通过减弱 JAK 信号和阻塞 STAT3 信号起作用。Brevilin A 通过线粒体途径和 PI3K/AKT/mTOR 失活诱导结肠腺癌细胞 CT26 的凋亡和自噬。

货号：ajce55350
CAS：16503-32-5
分子式：C20H26O5
分子量：346.42
纯度：98%
存储：Store at -20°C
库存：现货

Background:

Brevilin A is a sesquiterpene lactone isolated from Centipeda minima with anti-tumor activity. Brevilin A is a selective inhibitor of JAK-STAT signal pathway by attenuating the JAKs activity and blocking STAT3 signaling (IC50 = 10.6 µM) in Cancer Cells. Brevilin A induces apoptosis and autophagy via mitochondrial pathway and PI3K/AKT/mTOR inactivation in colon adenocarcinoma cell CT26[1][2]. IC50: 10.6 µM (STAT3 signaling)[1]

[1]. Chen X, et al. Brevilin A, a novel natural product, inhibits janus kinase activity and blocks STAT3 signaling in cancer cells. PLoS One. 2013 May 21;8(5):e63697. [2]. You P, et al. Brevilin A induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation. Biomed Pharmacother. 2018 Feb;98:619-625.